Signaling pathways
-
C8703 Saxagliptin HydrochlorideSummary: A selective, reversible dipeptidyl peptidase?4 (DPP?4) inhibitor -
C8704 Elagolix SodiumSummary: Oral non-peptide GnRH receptor antagonist -
C8706 Pantoprazole SodiumSummary: Benzimidazole proton pump inhibitor (PPI) -
C8707 Quinine bisulfateSummary: An antimalarial drug whose primary target is the hemoglobin metabolism pathway during the intraerythrocytic stage of Plasmodium. -
C8708 Glycerol PhenylbutyrateSummary: A triglyceride prodrug form for chronic hyperammonemia control in urea cycle disorders -
C8709 VimseltinibSummary: An orally available, highly selective CSF1R tyrosine kinase inhibitor -
C8710 Fluticasone FuroateSummary: High-affinity synthetic glucocorticoid, GR receptor agonist

